Combined knockout of Lrrk2 and Rab29 does not result in behavioral abnormalities in vivo (2020).
Mazza, C.M., Nguyen, V., Beilina, A., Karakoleva, E., Coyle, M., Ding, J., Bishop, C., & Cookson, M.Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats (2020)
Chambers, N., Coyle, M., Sergio, S., Lanza, K., Saito, C,. Topping, B., Clark, S., & Bishop, C.Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia (2020)
Lanza, K., Centner, A., Coyle, M., Del Priore, I., Manfredsson, F., & Bishop, C.Dopamine receptor cooperativity synergistically drives dyskinesia, motor behavior, and striatal GABA neurotransmission in hemiparkinsonian rats (2020)
Kiessling, C., Lanza, K., Feinberg, E., & Bishop, C.Neuroinflammation: Fanning the fire of l-dopa-induced dyskinesia (2019)
Bishop, C.Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson’s Disease (2019)
Chambers, N., Lanza, K., & Bishop, C.Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia (2019)
Sellnow, R., Newman, J., Chambers, N., West, A., Steece-Collier, K., Sandoval, I., Benskey, M., Bishop, C., & Manfredsson, F.Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat (2019)
Lanza, K., Chemakin, K., Lefkowitz, S., Saito, C., Chambers, N., & Bishop, C.Late aging–associated increases in L-DOPA–induced dyskinesia are accompanied by heightened neuroinflammation in the hemi-parkinsonian rat (2019)
Lanza, K., Perkins, A., Deak, T., & Bishop, C.Effects of Muscarinic Acetylcholine M1 and M4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat (2019)
Chambers, N., Meadows, S., Taylor, A., Sheena, E., Lanza, K., Conti, M., & Bishop, C.Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus Accumbens (2019)
Guitart, X., Moreno, E., Rea, W., Sanchez-Soto, M., Cai, N., Quiroz, C., Kumar, V., Bourque, L., Cortes, A., Canela, E. I., Bishop, C., Newman, A., Casado, V., & Ferre, S.Diverse serotonin actions of vilazodone reduce l‐3,4‐dihidroxyphenylalanine–induced dyskinesia in hemi‐parkinsonian rats (2018)
Meadows, S., Conti, M., Gross, L., Chambers, N., Avnor, Y., Ostock, C., Lanza, K., & Bishop, C.Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia (2018)
Lanza, K., Meadows, S., Chambers, N., Nuss, E., Deak, M., Ferre, S., & Bishop, C.Striatal norepinephrine efflux in L-DOPA-induced dyskinesia (2018)
Ostock, C., Bhide, N., Goldenberg, A., George, J., & Bishop, C.A new outlook on cholinergic interneurons in Parkinson’s disease and L-DOPA-induced dyskinesia (2018)
Conti, M., Chambers, N., & Bishop, C.Serotonergic targets for the treatment of l‑DOPA‑induced dyskinesia (2018)
Lanza, K., & Bishop, C.Characterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of L-DOPA-induced dyskinesia (2017)
Meadows, S., Chambers, N., Conti, M., Bossert, S., Tasber, C., Sheena, E., Varney, M, Newman-Tancredi, A., & Bishop, C.The Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in L-DOPA-Induced Dyskinesia in Parkinsonian Rats (2016)
Lindenbach, D., Conti, M., Ostock, C., George, J., Goldenberg, A., Melikhov-Sosin, M., Nuss, E., & Bishop, C.Monoamine transporter contributions to L-DOPA effects in hemiparkinsonian rats (2016)
Conti, M., Meadows, S., Melikhov-Sosin, M., Lindenbach, D., Hallmark, J., Werner, D., & Bishop, C.Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats (2016)
Conti, M., Goldenberg, A., Kuberka, A., Mohamed, M., Eissa, S., Lindenbach, D., & Bishop, C.Alterations in Primary Motor Cortex Neurotransmission and Gene Expression in Hemi-parkinsonian rats with Drug-Induced Dyskinesia (2015)
Lindenbach, D., Conti, M., Ostock, K., Dupre, B., & Bishop, C.Modulation of L-DOPA’s antiparkinsonian and dyskinetic effects by alpha2-noradrenergic receptors within the locus coeruleus (2015)
Ostock, C., Hallmark, J., Palumbo, N., Bhide, N., Conti, M., George, J., & Bishop, C.Effects of the beta‐adrenergic receptor antagonist Propranolol on dyskinesia and L‐DOPA‐induced striatal DA efflux in the hemi‐parkinsonian rat (2015)
Bhide, N., Lindenbach, D., Barnum, C., George, J., Surrena, M., & Bishop, C.Side effect profile of 5-HT treatments for Parkinson’s disease and L-DOPA-induced dyskinesia in rats (2015)
Lindenbach, D., Palumbo, N., Ostock, C., Vilceus, N., Conti, M., & Bishop, C.Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemiparkinsonian rats (2014)
Conti, M., Ostock, C., Lindenbach, D., Goldenberg, A., Kampton, E., Dell’isola, R., Katzman, A., & Bishop, C.Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat (2014)
Ostock, C., Lindenbach, D., Goldenberg, A., Kamptom, E., & Bishop, C.Critical Involvement of the Motor Cortex in the Pathophysiology and Treatment of Parkinson’s Disease (2013)
Lindenbach, D., & Bishop, C.The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat (2013)
Bhide, N., Lindenbach, D., Surrena, M., Goldenberg, A., Bishop, C., Berger, S., & Paquette, M.L-Dopa-Induced Dysregulation of Extrastriatal Dopamine and Serotonin and Affective Symptoms in a Bilateral Rat Model of Parkinson’s Disease (2012)
Eskow Jaunarajs, E., George, J., & Bishop, C.Serotonin transporter inhibition attenuates L-DOPA-induced dyskinesia without compromising L-DOPA efficacy in hemi-parkinsonian rats (2012)
Bishop, C., George, J., Buchta, W., Goldenberg, A., Mohamed, M., Dickinson, S., Eissa, S., Eskow Jaunarajs, K.Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats (2012)
Barnum, C., Bhide, N., Lindenbach, D., Surrena, M., Goldenberg, A., Tignor, S., Klioueva, A., Walters, H., & Bishop, C.Pathophysiology of Non-Dopaminergic Monoamine Systems in Parkinson’s Disease: Implications for Mood Dysfunction (2011)
Bhide, N., & Bishop, C.Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats (2011)
Dupre, K., Ostock, C., Eskow, Eskow Jaunarajs, K., Button, T., Savage, L., Wolf, W., & Bishop, C.Tryptophan Hydroxylase 2 Aggregates through Disulfide Cross-Linking upon Oxidation: Possible Link to Serotonin Deficists and Non-Motor Systems in Parkinson’s Disease (2011)
Kuhn, D., Sykes, C., Geddes, T., Eskow Jaunarajs, K., & Bishop, C.Behavioral and Cellular Modulation of L-DOPA-Induced Dyskinesia by β-Adrenoceptor Blockade in the 6-Hydroxydopamine-Lesioned Rat (2011)
Lindenbach, D., Ostock, C., Eskow Jaunarajs, K., Dupre, K., Barnum, C., Bhide, N., & Bishop, C.Role of the primary motor cortex in L-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation (2011)
Ostock, C., Dupre, K., Eskow Jaunarajs, K., Walters, H., George, J., Krolewski, D., Walker, P., & Bishop, C.Behavioral and neurochemical effects of chronic L-DOPA treatment on non-motor sequelae in the hemiparkinsonian rat (2010)
Eskow Jaunarajs, K., Dupre, K., Ostock, C., Botton, T., Deak, T., & Bishop, C.Potential mechanisms underlying anxiety and depression in Parkinson’s disease: Consequences of l-DOPA treatment (2010)
Eskow Jaunarajs, K., Angoa-Perez, M., Kuhn, D., & Bishop, C.The Role of the Dorsal Raphe Nucleus in the Development, Expression, and Treatment of L-dopa-Induced Dyskinesia in Hemiparkinsonian Rats (2009)
Eskow Jaunarajs, K., Dupre, K., Barnum, C., Dickinson, S., Park, J., & Bishop, C.Serotonin 1B Receptor Stimulation Reduces D1 Receptor Agonist-Induced Dyskinesia (2009)
Eskow Jaunarajs, K., Dupre, K., Steiniger, A., Klioueva, A., Moore, A., Kelly, C., & Bishop, C.Contribution of the Striatum to the Effects of 5-HT1A Receptor Stimulation in L-DOPA-treated Hemiparkinsonian Rats (2009)
Bishop, C., Krolewski, D., Eskow Jauranajs, K., Barnum, C., Dupre, K., Deak, T., & Walker, P.A Potential Neuroanatomical Dissociation of DARPP-32 in Striatal ERK Signaling (2008)
Dupre, K.Exogenous Corticosterone Reduces L-DOPA-Induced Dyskinesia in the Hemi-Parkinsonian Rat: Role for Interleukin-1 Beta (2008)
Barnum, C., Eskow Jauranajs, K., Dupre, K., Blandino JR., P., Deak, T., & Bishop, C.Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat (2008)
Dupre, K., Eskow Jauranajs, K., Steiniger, A., Klioueva, A., Negron, G., Lormand, L., Park, J., & Bishop, C.The differential effects of 5-HT1A receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat (2007)
Dupre, K., Eskow Jauranajs, K., NEgron, G., & Bishop, C.The partial 5-HT1A agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy (2007)
Eskow Jauranjas, K., Gupta, V., Alam, S., Park, J., & Bishop, C.MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation (2006)
Bishop, C., Taylor, J., Kuhn, D., Eskow Jauranjas, K., Park, J., & Walker, P.Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat (2005)
Taylor, J., Bishop, C., Ulrich, T., Rice, K., Walker, P.Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958 (2005)
Bishop, C., Daut, G., & Walker, P.Intrastriatal Dopamine D1 Receptor Agonist-Mediated Motor Behavior Is Reduced by Local Neurokinin 1 Receptor Antagonism (2005)
Krolewski, D., Bishop, C., & Walker, P.Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat (2005)
Taylor, J., Bishop, C., & Walker, P.Serotonin 5-HT2A Receptors Underlie Increased Motor Behaviors Induced in Dopamine-Depleted Rats by Intrastriatal 5-HT2A/2C Agonism (2004)
Bishop, C., Tessmer, J., Ullrich, T., Rice, K., & Walker, P.Intranigral antagonism of neurokinin 1 and 3 receptors reduces intrastriatal dopamine D1 receptor-stimulated locomotion in the rat (2004)
Bishop, C., & Walker, P.Intrastriatal Serotonin 5-HT2 Receptors Mediate Dopamine D1-Induced Hyperlocomotion in 6-HydroxydopamineLesioned Rats (2003)
Bishop, C., Kamdar, D., & Walker, P.Combined Intrastriatal Dopamine D1 and Serotonin 5-HT2 Receptor Stimulation Reveals a Mechanism for Hyperlocomoion in 6-Hydroxydopamine-Lesioned Rats (2003)
Bishop, C., & Walker, P.